Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC

August 14, 2026 4:26 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), that are or may be deemed beneficially owned by Redmile Group, LLC and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by Jeremy C. Green and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by RedCo II Offshore SPV LLC and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G



Redmile Group, LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member
Date:08/14/2026
Jeremy C. Green
Signature:/s/ Jeremy C. Green
Name/Title:Jeremy C. Green
Date:08/14/2026
RedCo II Offshore SPV LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member of Redmile Group, LLC, its manager
Date:08/14/2026

Categories

SEC Filings